SCHEMBL24637155

SCHEMBL24637155

C#CC[C@H](CC(=O)OCC)NC(C)=O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MGAM O43451 1/20 0.39
GAA P10253 1/20 0.39
SI P14410 1/20 0.39
MGAM2 Q2M2H8 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.34
ITGB3 P05106 1/20 0.34
ITGA2B P08514 1/20 0.34
ALDH1A1 P00352 5/20 0.33
TRPA1 O75762 1/20 0.33
ACACB O00763 1/20 0.33
KMT2A Q03164 2/20 0.33
CYP3A4 P08684 2/20 0.33
ALOX15 P16050 2/20 0.33
POLB P06746 1/20 0.33
TSHR P16473 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
CRAT P43155 1/20 0.33
HSD17B10 Q99714 2/20 0.32
LMNA P02545 1/20 0.32
CHRM1 P11229 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23138664 0.85 CRAT (0.35) MGAMGAASIMGAM2ACACB
SCHEMBL11126995 0.84 MGAM (0.50) MGAMGAASIMGAM2L3MBTL1
SCHEMBL21327975 0.81 MGAM (0.46) MGAMGAASIMGAM2L3MBTL1
SCHEMBL1405748 0.78 MGAM (0.43) MGAMGAASIMGAM2L3MBTL1
SCHEMBL11126678 0.78 MGAM (0.43) MGAMGAASIMGAM2L3MBTL1
SCHEMBL11126682 0.78 MGAM (0.43) MGAMGAASIMGAM2L3MBTL1
SCHEMBL4156137 0.77 CNR2 (0.42) MGAMGAASIMGAM2L3MBTL1
SCHEMBL592891 0.75 PLA2G2C (0.53) MGAMGAASIMGAM2L3MBTL1
SCHEMBL18946197 0.75 CAD (0.40) MGAMGAASIMGAM2L3MBTL1
SCHEMBL1071728 0.75 CAD (0.40) MGAMGAASIMGAM2L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220323415-A1 L-PAG DERIVATIVES FOR TREATMENT OF SLEEP DISORDERED BREATHING (SDB) IIT RESEARCH INSTITUTE 2022-10-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220323415-A1 L-PAG DERIVATIVES FOR TREATMENT OF SLEEP DISORDERED BREATHING (SDB) GLRB, GABRB3, GABRB1 MGAM 3436/4885GAA 1415/4885SI 2929/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.